Azacitidine is removed effectively by hemodialysis

Click to increase image sizeClick to decrease image size

Acknowledgements

This work is dedicated to the memory of our colleague Michael Steurer MD, Associate Professor, former vice head of the Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, who passed away on 11th March 2019 at the age of 49 years.

Disclosure statement

Reinhard Stauder: Celgene: Honoraria, Membership on an entity’s Board of Directors or advisory committees; Novartis: Honoraria, Membership on an entity’s Board of Directors or advisory committees;

Arno G. E. Beer: None

H. Neuwirt: Sanofi–Advisory Board, Astellas–Honoraria and grant support, Novartis–Honoraria

G. Mayer: grant support: Otsuka, Teva; Advisory Board and speaker honoraria: Astellas, Boehringer Ingelheim, Vifor, Novartis, Otsuka, Eli Lilly

E. Laille: Employment and stock ownership: Bristol Myers Squibb (formerly Celgene Corporation).